DETAILS
RECOMBITEK® Canine Parvo vaccine contains canine parvovirus, propagated in a stable cell line. Safety and efficacy of this product have been demonstrated by vaccination and challenge tests.
INDICATIONS
This product has been shown to be effective for the vaccination of healthy dogs, 6 weeks of age and older, against canine parvovirus. The duration of immunity has not been determined.
DOSAGE & ADMINISTRATION
Aseptically administer 1 mL (1 dose) subcutaneously or intramuscularly into healthy dogs. For primary vaccination, revaccinate with a second 1-mL dose 2 to 3 weeks later. The presence of maternal antibodies is known to interfere with the development of active immunity in dogs and additional boosters will be required in most young animals.
Precautions: Contains gentamicin and thimerosal as preservatives. In rare instances, administration of vaccines may cause lethargy, fever, and inflammatory or hypersensitivity types of reactions. Treatment may include antihistamines, anti-inflammatories, and/or epinephrine, as directed by a veterinarian. This product has not been tested in pregnant animals. In case of human exposure, contact a physician. Inactivate unused contents before disposal.
Store at 35-46ºF (2-8ºC). Do not freeze. Do not use chemicals to sterilize syringes and needles.
Do not mix with other products.
For use in animals only. Sold to veterinarians only.
